The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease.
Saved in:
| Title: | The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease. |
|---|---|
| Authors: | Kumar, Divya P.1 divyapkumar@jssuni.edu.in, Caffrey, Rebecca2, Marioneaux, Jonathon2, Santhekadur, Prasanna K.1, Bhat, Madhavi2, Alonso, Cristina3, Koduru, Srinivas V.4, Philip, Binu5, Jain, Mukul R.5, Giri, Suresh R.5, Bedossa, Pierre6, Sanyal, Arun J.7 arun.sanyal@vcuhealth.org |
| Source: | Scientific Reports. 6/9/2020, Vol. 10 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
